This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

      

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

DRY RUN - Act against AMR: Managing UTI with the Latest Susceptibility data

15-November-2023 3:00PM (IST)

15 Nov, 2023

Webinar

Register Now

Act against AMR: Managing UTI with the Latest Susceptibility data

 

This webinar talks about common epidemiology of UTI, its prevalence amongst women and how a proper guideline-treatment plan helps combat antimicrobial resistance in patients.

Nucala is now approved in 4 indications in Saudi Arabia and the objective of the meeting is to raise Saudi HCPs awareness about the management of Eosinophilic Driven Diseases

 

Speakers

 Speaker foto

Jeff J. Jubilado, MD

MHA, FPUA, FPCS, FICS

Present roles: Chief of Clinics & Department Chair (Surgery) -- Assumption Specialty Hospital and Medical Center ** Department Chair (Surgery) -- Pasig Doctors Medical Center. ** Department Chair (Urology) -- Marikina Valley Medical Center. ** Section Head (Urology) -- Marikina Doctors Hospital and Medical Center. ** Member American Urological Association European Association of Urology Urological Association of Asia ** Medical Affairs Manager (Urology) -- GSK Philippines

 Speaker foto

Allan Dexter M. Alejo, MD

DPDS

Medical Affairs Manager -- Anti-infectives and Dermatology, GSK Philippines.** Doctor of Medicine -- UST Faculty of Medicine and Surgery. ** Residency in Dermatology -- Skin and Cancer Foundation, Inc. ** Diplomate -- Philippine Dermatological Society.

PM-PH-ACA-WCNT-230002